Related references
Note: Only part of the references are listed.Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System
Eduardo Vilar-Gomez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
Wah-Kheong Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
Ankur Srivastava et al.
JOURNAL OF HEPATOLOGY (2019)
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
Jerome Boursier et al.
JOURNAL OF HEPATOLOGY (2019)
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
Ankur Srivastava et al.
BMC GASTROENTEROLOGY (2019)
How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Howard Libman et al.
ANNALS OF INTERNAL MEDICINE (2019)
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia
Miquel Serra-Burriel et al.
JOURNAL OF HEPATOLOGY (2019)
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castera et al.
GASTROENTEROLOGY (2019)
Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
James M. Paik et al.
HEPATOLOGY COMMUNICATIONS (2019)
Impact of Implementing a FIB-4 First Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
Tracy Davyduke et al.
HEPATOLOGY COMMUNICATIONS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis
Eva Herrmann et al.
HEPATOLOGY (2018)
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
Elliot B. Tapper et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease
P. J. Eddowes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Comparison of Laboratory Tests, Ultrasound, or Magnetic Resonance Elastography to Detect Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Guangqin Xiao et al.
HEPATOLOGY (2017)
Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
Lukasz Tanajewski et al.
BMJ OPEN (2017)
Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
Rodrigo Bremer Nones et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2017)
The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease
Elliot B. Tapper et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management
M. Shadab Siddiqui et al.
GASTROENTEROLOGY (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging
Laurence Blake et al.
BMJ OPEN (2016)
Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography
Elliot B. Tapper et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
A health technology assessment of transient elastography in adult liver disease
Rodney Steadman et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Don Husereau et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stuart McPherson et al.
GUT (2010)
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
HC Kim et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Share Paper
